Leonardo Gomes da Fonseca

25PUBLICATIONS
145CO-AUTHORS
Heterodox economicsHaematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|May 22, 2026
Beyond drug toxicity: the hidden burden of financial toxicity in hepatocellular carcinoma.

|Dec 03, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma: BAVENO VII Criteria Still Needs to Be Updated.

Federico Piñero, Margarita Anders, Leonardo da Fonseca

|Nov 12, 2025
Prognostic value of a simplified score based on routine parameters in patients with hepatocellular carcinoma treated with systemic therapies: a retrospective cohort study.

Leonardo G Da Fonseca, Thamires Haick Martins da Silveira, Victor Junji Yamamoto

|Aug 12, 2025
Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy.

Marta Fortuny, Leonardo G da Fonseca, Manon Allaire

|Jul 30, 2025
Effectiveness and Safety of Immunotherapy for Hepatocellular Carcinoma in Clinical Practice: A Brazilian Multicenter Study.

Leonardo Gomes da Fonseca, Cecília Souza Freire, Rodrigo Antonio Vieira Guedes

|Apr 10, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated Cirrhosis.

Federico Piñero, Margarita Anders, Carla Bermudez

Pageof 5

Frequent Collaborators

7 joint publications

Alejandro Forner

6 joint publications

Marco Sanduzzi-Zamparelli

5 joint publications

Víctor Sapena

5 joint publications

Jordi Bruix